Key facts
- It has raised $28.8M; the latest was Later Stage VC in Dec 2024.
- Notable investors include Plug and Play Tech Center, Microsoft for Startups, Hillhouse Investment Group, Hong Kong Science & Technology Parks, Proxima Ventures (China) — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Great Bay Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Great Bay Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Great Bay Bio
Developer of biotechnology and medical products based on artificial intelligence. The company has established a biomedicine development platform centered using artificial intelligence and big data technology, which significantly shortened the drug development cycle and greatly reduced development costs, enabling medical corporates to develop biological drugs in an easier and more efficient way.
- Sector
- Healthcare
- HQ
- Hong Kong, Hong Kong
- Founded
- 2019
- Website
- greatbay-bio.com/
- Ownership
- Privately Held (backing)
Great Bay Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Great Bay Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Great Bay Bio in its N-PORT filings yet. We sweep new filings monthly.